These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 18392709

  • 1. Does ampullary carcinoma arise from distended glands in the papilla of Vater?
    Sonoue H, Suda K, Nobukawa B, Abe H, Arakawa A, Hirai S, Matsumoto T.
    J Hepatobiliary Pancreat Surg; 2008; 15(2):161-8. PubMed ID: 18392709
    [Abstract] [Full Text] [Related]

  • 2. Distended glands or overreplacement of ampullary mucosa at the papilla of Vater.
    Suda K, Ootaka M, Yamasaki S, Sonoue H, Matsubara K, Takase M, Nobukawa B, Suzuki F.
    J Hepatobiliary Pancreat Surg; 2004; 11(4):260-5. PubMed ID: 15368111
    [Abstract] [Full Text] [Related]

  • 3. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
    Zhou H, Schaefer N, Wolff M, Fischer HP.
    Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
    Goldstein NS, Bassi D.
    Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
    Roh YH, Kim YH, Lee HW, Kim SJ, Roh MS, Jeong JS, Jung GJ.
    Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
    [Abstract] [Full Text] [Related]

  • 8. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
    Sanada Y, Yoshida K, Konishi K, Oeda M, Ohara M, Tsutani Y.
    Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y, Reid MD, Balci S, Quigley B, Muraki T, Memis B, Xia J, Hacihasanoglu E, Bedolla G, Pehlivanoglu B, Kim GE, Tajiri T, Ohike N, Aneja R, Krasinskas AM, Adsay V.
    Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
    [Abstract] [Full Text] [Related]

  • 11. Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
    Kawabata Y, Tanaka T, Nishisaka T, Inao T, Nishi T, Yano S.
    Diagn Pathol; 2010 Nov 25; 5():75. PubMed ID: 21106111
    [Abstract] [Full Text] [Related]

  • 12. Adenomyoma and adenomyomatous hyperplasia of the Vaterian system: clinical, pathological, and new immunohistochemical features of 13 cases.
    Handra-Luca A, Terris B, Couvelard A, Bonte H, Flejou JF.
    Mod Pathol; 2003 Jun 25; 16(6):530-6. PubMed ID: 12808057
    [Abstract] [Full Text] [Related]

  • 13. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I, Minaidou E, Leontara V, Mantas D, Sotiropoulos GC, Tsipras H, Zografos GN, Margaris I, Kouraklis G.
    Int J Surg Pathol; 2017 Feb 25; 25(1):31-40. PubMed ID: 27543509
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
    Morini S, Perrone G, Borzomati D, Vincenzi B, Rabitti C, Righi D, Castri F, Manazza AD, Santini D, Tonini G, Coppola R, Onetti Muda A.
    Pancreas; 2013 Jan 25; 42(1):60-6. PubMed ID: 22889982
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.
    Han L, Pansare V, Al-Abbadi M, Husain M, Feng J.
    Diagn Cytopathol; 2010 May 25; 38(5):333-6. PubMed ID: 19856421
    [Abstract] [Full Text] [Related]

  • 18. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
    Matsubayashi H, Watanabe H, Yamaguchi T, Ajioka Y, Nishikura K, Kijima H, Saito T.
    Cancer; 1999 Aug 15; 86(4):596-607. PubMed ID: 10440687
    [Abstract] [Full Text] [Related]

  • 19. Endocrine cells in ampullary carcinoma.
    Kamisawa T, Tu Y, Egawa N, Tsuruta K, Okamoto A, Funata N.
    J Hepatobiliary Pancreat Surg; 2009 Aug 15; 16(3):322-7. PubMed ID: 19214369
    [Abstract] [Full Text] [Related]

  • 20. Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
    Xue Y, Vanoli A, Balci S, Reid MM, Saka B, Bagci P, Memis B, Choi H, Ohike N, Tajiri T, Muraki T, Quigley B, El-Rayes BF, Shaib W, Kooby D, Sarmiento J, Maithel SK, Knight JH, Goodman M, Krasinskas AM, Adsay V.
    Mod Pathol; 2017 Feb 15; 30(2):255-266. PubMed ID: 27739441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.